IRIS Accounts Production v24.1.4.33 06030217 director 1.8.22 31.7.23 31.7.23 28/6/2024 0 0 true false true false false true true true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh060302172022-07-31060302172023-07-31060302172022-08-012023-07-31060302172021-07-31060302172021-08-012022-07-31060302172022-07-3106030217ns15:EnglandWales2022-08-012023-07-3106030217ns14:PoundSterling2022-08-012023-07-3106030217ns10:Director12022-08-012023-07-3106030217ns10:PrivateLimitedCompanyLtd2022-08-012023-07-3106030217ns10:SmallEntities2022-08-012023-07-3106030217ns10:Audited2022-08-012023-07-3106030217ns10:SmallCompaniesRegimeForDirectorsReport2022-08-012023-07-3106030217ns10:SmallCompaniesRegimeForAccounts2022-08-012023-07-3106030217ns10:FullAccounts2022-08-012023-07-3106030217ns10:RegisteredOffice2022-08-012023-07-3106030217ns5:CurrentFinancialInstruments2023-07-3106030217ns5:CurrentFinancialInstruments2022-07-3106030217ns5:ShareCapital2023-07-3106030217ns5:ShareCapital2022-07-3106030217ns5:RetainedEarningsAccumulatedLosses2023-07-3106030217ns5:RetainedEarningsAccumulatedLosses2022-07-3106030217ns5:CostValuation2022-07-31
REGISTERED NUMBER: 06030217 (England and Wales)















SAFFRONLAND CARE LIMITED

FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JULY 2023






SAFFRONLAND CARE LIMITED (REGISTERED NUMBER: 06030217)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


SAFFRONLAND CARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JULY 2023







DIRECTOR: Mr A M Lakhani





REGISTERED OFFICE: Maple House
121B Winchester Road
Chandlers Ford
Eastleigh
Hampshire
SO53 2DR





REGISTERED NUMBER: 06030217 (England and Wales)





AUDITORS: Rothmans Audit LLP
Statutory Auditors
Chartered Accountants
Fryern House
125 Winchester Road
Chandlers Ford
Hampshire
SO53 2DR

SAFFRONLAND CARE LIMITED (REGISTERED NUMBER: 06030217)

BALANCE SHEET
31 JULY 2023

2023 2022
Notes £ £ £ £
FIXED ASSETS
Investments 3 7,100,164 7,100,164

CREDITORS
Amounts falling due within one year 4 6,258,775 6,258,355
NET CURRENT LIABILITIES (6,258,775 ) (6,258,355 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

841,389

841,809

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 841,388 841,808
SHAREHOLDERS' FUNDS 841,389 841,809

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 27 June 2024 and were signed by:





Mr A M Lakhani - Director


SAFFRONLAND CARE LIMITED (REGISTERED NUMBER: 06030217)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023


1. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The presentation currency is £ sterling.

Going concern
The financial statements have been prepared on the going concern basis.

Consolidated financial statements
The financial statements contain information about Saffronland Care Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company has taken advantage of the exemption conferred by section 400 of the Companies Act 2006 not to produce consolidated financial statements as it is included in UK group accounts of a larger group.

Significant judgements and estimates
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported for assets and liabilities as at the balance sheet date, and the amounts reported for revenues and expenses during the year. However, the nature of estimation means that actual outcomes could differ from those estimates.

The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

1)Impairment of assets
Management use their judgement to determine if there are any indicators of impairment.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Dividends
Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid and final equity dividends are recognised when approved by the shareholders at an annual general meeting.

SAFFRONLAND CARE LIMITED (REGISTERED NUMBER: 06030217)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2023


1. ACCOUNTING POLICIES - continued

Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the Income Statement. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

2. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

3. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£
COST
At 1 August 2022
and 31 July 2023 7,100,164
NET BOOK VALUE
At 31 July 2023 7,100,164
At 31 July 2022 7,100,164

4. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£ £
Amounts owed to group undertakings 6,254,754 6,254,334
Other creditors 723 723
Accruals and deferred income 3,298 3,298
6,258,775 6,258,355

5. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Liz Martyn ACA (Senior Statutory Auditor)
for and on behalf of Rothmans Audit LLP

6. CONTINGENT LIABILITIES

The company has a cross guarantee with its holding company, Saffronland Group Limited, in favour of Coutts & Company to guarantee its loan. The total indebtedness at the balance sheet date was £16,558,000 (2022: £16,904,000).

SAFFRONLAND CARE LIMITED (REGISTERED NUMBER: 06030217)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2023


7. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

8. ULTIMATE PARENT COMPANY AND ULTIMATE CONTROLLING PARTY

The company's immediate parent undertaking is Saffronland Group Limited and its ultimate parent undertaking is Saffronland Investments Limited, a company incorporated in England and Wales. The ultimate control of that company is exercised by Mr A M Lakhani.

The largest and smallest group in which the results of the company are consolidated is that headed by Saffronland Investments Limited, incorporated in England & Wales. The consolidated accounts of this company are available to the public and may be obtained from Companies House. No other group accounts include the results of the company.